Weight Management
GLP-1 Retatrutide
Retatrutide
Triple Receptor Agonist
Retatrutide is a triple receptor agonist (GLP-1/GIP/Glucagon) that decreases body weight by ~25% with less GI distress.
Indications
Weight Management
- — Triple agonist
- — Decreases body weight by ~25%
- — Less GI distress
- — More energy
Price
$450
Strength
Medication Details
30 mg
Concentration: 0.1 mg/unit
Bacteriostatic Water 3 mL
Dosing
Once weekly
Administration
Subcutaneous
Injection Technique
- • Inject subcutaneously into abdomen, thigh, or upper arm
- • Rotate injection sites
- • Clean site, pinch skin, inject at 90° angle
- • Dispose of syringe in sharps container
Missed Dose
- • Take within 5 days if remembered
- • If more than 5 days, skip and resume weekly schedule
- • Do not double dose
Storage & Handling
Refrigerate after reconstitution (36°F–46°F / 2°C–8°C). Do not freeze. Protect from light. Discard after 90 days.
Notes
Triple receptor agonist for weight management.
Consult your prescribing Healthcare Provider for dosing adjustments.
Disclaimer
This medication is compounded and provided for use only under the supervision of a licensed healthcare provider. Use only as prescribed. Individual results may vary.
Version 2.2 | Effective Date: January 31, 2026
Physician-reviewed before dispensing
Medical records maintained
Telehealth consultation available
